Literature DB >> 10747992

Steady-state regulation of the human DNA mismatch repair system.

D K Chang1, L Ricciardiello, A Goel, C L Chang, C R Boland.   

Abstract

Steady-state levels of human DNA mismatch repair (MMR) transcripts and proteins were measured in MMR-proficient and -deficient cell lines by the newly developed competitive quantitative reverse transcription- polymerase chain reaction and Western analysis normalized with purified proteins. In MMR-proficient cells, hMSH2 is the most abundant MMR protein and is expressed 3 to 5 times more than hMLH1. The hMLH1 protein was expressed 1.5 to 2.5 times more than hPMS2. Steady-state levels of mRNA expression correlated well with protein expression. hMSH2-mutated LoVo cells did not express detectable hMSH3 or hMSH6 proteins. Similarly, hMLH1-mutated HCT116 cells did not express detectable hMLH1 or hPMS2 protein, whereas in hMLH1-restored HCT116+ch3 cells, hPMS2 protein was re-expressed. In hMSH6-mutated HCT15 cells, both hMSH3 protein and mRNA were increased. In SV40-transformed lung fibroblasts, all MMR mRNAs and proteins examined were expressed at levels 1.5-5-fold higher than in their nontransformed counterpart. The steady-state levels of MMR proteins indicate that substantially more hMutS proteins, which are involved in DNA mismatch recognition, are present in comparison with the hMutL proteins. Stability of hMSH3 and hMSH6 proteins appears to depend upon the presence of the hMSH2 protein, and, similarly, the stability of the hPMS2 protein depends upon hMLH1. When the hMSH6 is mutationally inactivated, hMSH3 increases by both transcriptional up-regulation and enhanced protein stability. A balanced up-regulation of all of the components was seen after viral transformation in a fibroblast model. Quantitative changes of the MMR components are a potential mechanism to modify the DNA MMR capabilities of a cell.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747992     DOI: 10.1074/jbc.M001140200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

2.  Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.

Authors:  A Brieger; J Trojan; J Raedle; G Plotz; S Zeuzem
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

3.  Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.

Authors:  Jan Kosinski; Inga Hinrichsen; Janusz M Bujnicki; Peter Friedhoff; Guido Plotz
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

4.  Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.

Authors:  Xiaosheng Wu; Jeffrey L Platt; Marilia Cascalho
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

5.  Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression.

Authors:  Meysam Moghbeli; Omeed Moaven; Bahram Memar; Hamid Reza Raziei; Azadeh Aarabi; Ezzat Dadkhah; Mohammad Mahdi Forghanifard; Fatemeh Manzari; Mohammad Reza Abbaszadegan
Journal:  J Gastrointest Cancer       Date:  2014-03

6.  Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients.

Authors:  Eduard Sidelnikov; Roberd M Bostick; W Dana Flanders; Qi Long; Veronika Fedirko; Aasma Shaukat; Carrie R Daniel; Robin E Rutherford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

7.  Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Clement Richard Boland
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

Review 8.  The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.

Authors:  C Richard Boland; Minoru Koi; Dong K Chang; John M Carethers
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

9.  Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression.

Authors:  Ujani Chakraborty; Timothy A Dinh; Eric Alani
Journal:  Genetics       Date:  2018-04-13       Impact factor: 4.562

10.  Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium.

Authors:  Dimitra P Vageli; Stavros Giannopoulos; Sotirios G Doukas; Christos Kalaitzis; Stilianos Giannakopoulos; Alexandra Giatromanolaki; George K Koukoulis; Stavros Touloupidis
Journal:  Oncol Lett       Date:  2012-10-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.